Strangulated small bowel through vaginal vault rupture: late complication of abdominal sacrocolpopexy
© Springer-Verlag 2008
Received: 18 August 2008
Accepted: 6 October 2008
Published: 4 November 2008
Sacrocolpopexy is currently a favourable procedure for management of apical defect and vaginal vault prolapse. Recently, it has been extensively evaluated in terms of its efficacy, durability and potential short- and long-term complications. These complications have been investigated by many authors, including urinary retention, urge incontinence, urinary tract infections, wound infection, haematomas, bowel symptoms and gastrointestinal complications. However, we report the first case of strangulated small bowel due to herniation through vaginal vault rupture as a late complication of sacrocolpopexy. This report reviews the risk factors and precipitating causes of bowel evisceration particularly after sacrocolpopexy, and peri- and intraoperative preventive measures are discussed, as well as various management modalities.
KeywordsSacrocolpopexy Vault rupture Evisceration Bowel herniation Strangulation Mesh erosion
Abdominal sacrocolpopexy remains the preferred option over vaginal sacrospinous fixation for post-hysterectomy vault prolapse in terms of reduced recurrent prolapse rates. Complications of abdominal sacrocolpopexy are common but usually self-limiting (urinary retention, urge incontinence, urinary tract infections, wound infections, haematomas, etc). Mesh erosion is a significant concern, especially when the mesh is placed vaginally. Serious complications are very uncommon.
We report here the first case of strangulated small bowel due to herniation through vaginal vault rupture as a late complication of sacrocolpopexy.
A 75-year-old woman was referred as an emergency from primary care. She found “something” prolapsing from her vagina after she had blown her nose and felt something “give way” inside. She presented 6 h later, with lower abdominal pain and vomiting. She was hypertensive and hypothyroid and was undergoing a course of palliative chemotherapy (Epirubicin, cisplatin, 5-FU) for an inoperable oesophageal cancer, which had been diagnosed 7 months earlier. She had been celibate for several years.
She had undergone vaginal hysterectomy and pelvic floor repair 22 years previously for uterovaginal prolapse. She had undergone a posterior vaginal repair and anterior vaginal repair with Surgisis® Soft Tissue Graft (Cook Biotech Incorporated (CBI), West Lafayette, IN, USA) 4 years previously. Three years previously, she had undergone open abdominal sacrocolpopexy for vaginal vault prolapse and recurrent cystocele. Type I macroporous (>70 μm) polypropylene mesh (Ethicon Endo-Surgery, Johnson and Johnson, Cincinnati, OH, USA) was sutured by monofilament, non-braided permanent suture (Prolene size 0) to the vaginal vault and with titanium spiral staples (Protack 5 mm autosuture, Tyco Healthcare stapler) to the pre-sacral longitudinal ligaments approximately at the level of the third sacral segment (S-3). The mesh was re-peritonealised. Prophylactic antibiotics were given with anaesthetic induction. At 6 weeks post-operative review, pelvic examination revealed a well-healed and supported vaginal vault with no granulation tissues or evidence of mesh erosion.
Vaginal rupture and bowel evisceration is an extremely rare life-threatening clinical condition that requires immediate surgical management. A search of Medline from January 1950 to April 2008 was carried out in a non-restricted language, with a key word search using “sacrocolpopexy”, “vault rupture”, “vaginal rupture”, “evisceration”, “bowel herniation”, “strangulation” and “mesh erosion”.
There have been very few cases, in the literature, since McGregor in 1907 reported the first case of spontaneous vaginal rupture as cited . It is relatively more common in post-menopausal women, presumably due to the hypo-estrogenism and consequent vaginal atrophy, thinning and de-vascularisation of previously healthy vaginal tissue. A short atrophic vagina is a particular risk for rupture . However, in pre-menopausal women, vaginal rupture is less common and usually follows vaginal trauma by vigorous sexual intercourse, introduction of vaginal foreign bodies and traumatic vaginal deliveries.
Hysterectomy, either abdominal and more commonly vaginally, and previous vaginal prolapse repair particularly enterocele and are recognised as risk factors for vaginal rupture. Dissection during vaginal surgery devascularises tissues and compromises the integrity of vaginal fascia and encourages vaginal shortening . Prolonged use of vaginal pessaries for vaginal prolapse may lead to stretching, thinning, ulceration and weakness of the vaginal tissues and increase the risk of vaginal rupture particularly if vaginal surgical repair is subsequently used to manage the prolapse.
Other risk factors for vaginal rupture include connective tissue disorders, pelvic irradiation, post-operative vault haematomas and infection, corticosteroid therapy, high body mass index and smoking. Another possible risk factor specific to this present case is the fact that the patient had a course of chemotherapy for oesophageal cancer. It has been reported that chemotherapeutic agents, especially anthracyclines (e.g. aclarubicin, daunorubicin, doxorubicin,  epirubicin and idarubicin) predispose to mucositis and vaginal atrophy.
Vaginal rupture usually follows a direct precipitating cause due to sudden rise in the intra-abdominal pressure such as straining during defection, coughing, blowing the nose or heavy lifting.
Sacrocolpopexy is a particular risk for vaginal rupture because it is usually performed in patients who have vaginal vault prolapse often with several previous pelvic surgeries, commonly in post-menopausal patients, and usually, it is associated with enterocele. Insertion of synthetic mesh in sacrocolpopexy may lead to further weakness of the vaginal fascia particularly if it is complicated with infection and mesh erosion. Furthermore, sacrocolpopexy changes the normal axis of the vagina as it brings the vagina in a more vertical plan rather than its normal anatomical almost horizontal plan resting on the levator plate. The angle of inclination of the upper vagina to the horizontal is normally less than 45° . During increased intra-abdominal pressure, the vaginal axis becomes even more horizontal, and the angle of inclination is reduced to virtually zero so that the vagina is maintained well supported above the levator plate . This important mechanism protects the vaginal vault, which is the weakest part of the vagina, during straining. Moreover, the tension created by the mesh of the sacrocolpopexy on the vaginal apex adds to the weakness of the vaginal vault and increases the risk of tearing and rupture of the vagina.
Post-hysterectomy vaginal shortening is a risk factor for vaginal rupture in patients subsequently undergoing sacrocolpopexy, as the shortened vagina lies directly in the plane of the genital hiatus unsupported by the levator plate and prolapses more readily, making it more prone to rupture. Further, short vagina requires a relatively greater length of mesh. This may increase the risk of vaginal stretching and avulsion of the mesh from the vault secondary to tension from the mesh as it shrinks and retracts. It has been shown that polypropylene meshes shrink to about 30–50% of their original size after 4 weeks of insertion in animal models  and also when removed after abdominal hernia repair .
The risk of vaginal rupture following sacrocolpopexy can be reduced by adapting the surgical technique to reduce the tension on the mesh attached to the vaginal apex with a tendency of under-correction of vault prolapse that makes the vagina less stretched and leaving the vagina more horizontal rather than vertical to reduce risk of vaginal rupture. Furthermore, deep fixation of the mesh, preferably at S-3 segment, may reduce the risk of vault rupture as this makes vaginal axis more horizontal. Furthermore, the use of minimal amount of mesh accompanied with tension-free application with avoidance of combined abdominal and vaginal surgery minimise the potential risk of complication.
Peri-operative prophylactic antibiotic reduces infection, and mesh erosion rates consequently reduce the risk of vaginal rupture. Coexistent vaginal atrophy should be treated with hormonal therapy to minimise risk of vaginal tearing during apical suturing. Pre-operative assessment is essential to identify high-risk patients with multiple previous prolapse operations with possible atrophic and very thin vaginal vault. Non-sacropexy solutions to apical prolapse, e.g. sacrospinous fixation may be considered for those patients. Nevertheless, vaginal rupture and bowel evisceration have been reported following sacrospinous vaginal vault fixation . Furthermore, randomised trials [9, 10] have clearly demonstrated that abdominal techniques are superior to the vaginal approach.
Furthermore, pre-operative counselling is essential, and patients should be advised to avoid post-operative chronic increase in intra-abdominal pressure by avoiding heavy lifting, weight gain, smoking and chronic constipation.
Vaginal rupture and bowel evisceration can be repaired vaginally, abdominally or by a combined approach. Laparoscopic management has been described. Concomitant surgical repair of associated vaginal prolapse and pelvic floor repair during surgical management of evisceration has been advocated by some authors; however, others recommend delayed pelvic repair after the primary tissue rupture sites have healed. Cul-de-sac obliteration or colpocleisis have been suggested in patients who wish to abstain from sexual intercourse .
- Karam JA, Wengert PA, Kerstein MD (1995) Vaginal evisceration. South Med J 88(3):355–356, ISSN: 0038-4348, MarPubMedGoogle Scholar
- Croak AJ, Gebhart JB, Klingele CJ, Schroeder G, Lee RA, Podratz KC (2004) Characteristics of patients with vaginal rupture and evisceration. Obstet Gynecol 103(3):572–576, ISSN: 0029-7844, MarPubMedGoogle Scholar
- Krychman ML, Carter J, Aghajanian CA, Dizon DS, Castiel M (2004) Chemotherapy induced dyspareunia: a case study of vaginal mucositis and pegylated liposomal doxorubicin injection in advanced stage ovarian carcinoma. Gynecol Oncol 93(2):561–563, ISSN: 0090-8258, MayView ArticlePubMedGoogle Scholar
- Petros PE (2001) Vault prolapse I: dynamic supports of the vagina. Int Urogynecol J Pelvic Floor Dysfunct 12(5):292–295, ISSN: 0937-3462View ArticlePubMedGoogle Scholar
- Virtanen HS, Ekholm E, Kiilholma PJ (1996) Evisceration after enterocele repair: a rare complication of vaginal surgery. Int Urogynecol J Pelvic Floor Dysfunct 7(6):344–347, 27 refs, ISSN: 0937-3462View ArticlePubMedGoogle Scholar
- Klinge U, Klosterhalfen B, Müller M, Ottinger AP, Schumpelick V (1998) Shrinking of polypropylene mesh in vivo: an experimental study in dogs. Eur J Surg 164(12):965–969, ISSN: 1102-4151, DecView ArticlePubMedGoogle Scholar
- Baessler K, Maher-Christopher F (2006) Mesh augmentation during pelvic-floor reconstructive surgery: risks and benefits. Curr Opin Obstet Gynecol 18(5):560–566, 51 refs, ISSN: 1040-872X, OctView ArticlePubMedGoogle Scholar
- Farrell SA, Scotti RJ, Ostergard DR, Bent AE (1991) Massive evisceration: a complication following sacrospinous vaginal vault fixation. Obstet Gynecol 78(3 Pt 2):560–562, ISSN: 0029-7844, SepPubMedGoogle Scholar
- Benson JT, Lucente V, McClellan E. (1996) Vaginal versus abdominal reconstructive surgery for the treatment of pelvic support defects: a prospective randomized study with long-term outcome evaluation. [Clinical Trial. Comparative Study. Journal Article. Randomized Controlled Trial] Am J Obstet Gynecol 175(6):1418–21; discussion 1421-2, DecView ArticlePubMedGoogle Scholar
- Maher C, Baessler K, Glazener CM, Adams EJ, Hagen S, (2004) Surgical management of pelvic organ prolapse in women. [update in Cochrane Database Syst Rev. 2007;(3):CD004014; PMID: 17636742]. [Review] [44 refs] [Journal Article. Meta-Analysis. Review] Cochrane Database of Systematic Reviews (4):CD004014Google Scholar